Mottola Frank
SVP, Chief Tech. Ops. Officer at SUPERNUS PHARMACEUTICALS, INC.
- Sold, on record
- $2.7M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Mar 9, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeNov 14, 2023 2023
Filed to sell 1,110 shares ($31k)
Mottola Frank, Officer
No 10b5-1 planFiling
- 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planNov 14, 2023 same day
Sold 1,110 shares at $28.13 ($31k)
Mottola Frank, SVP, Quality, GMP, Ops, IT
No 10b5-1 planSold 16.3% of holdings ($191k position)5,681 shares leftFollows a Form 144Filing
- 3 Form 144 notice SUPERNUS PHARMACEUTICALS, INC.NoticeNov 7, 2024 +359 days
Filed to sell 15,000 shares ($555k)
Mottola Frank, Officer
No 10b5-1 planFiling
- 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualNov 7, 2024 same day
Sold 15,000 shares at $36.98 ($555k)
Mottola Frank, SVP, Quality, GMP, Ops, IT
No 10b5-1 planSold 64.7% of holdings ($858k position)8,200 shares leftFollows a Form 144Filing
- 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualAug 25, 2025 +291 days
Sold 14,000 shares at $44.51 ($623k)
Mottola Frank, SVP, Quality, GMP, Ops, IT
No 10b5-1 planSold 47.5% of holdings ($1.3M position)15,496 shares leftFiling
- 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planSep 12, 2025 +18 days
Sold 5,000 shares at $45.87 ($229k)
Mottola Frank, SVP, Chief Tech. Ops. Officer
No 10b5-1 planSold 24.4% of holdings ($940k position)15,496 shares left0.4x usual sizeFiling
- 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineDec 19, 2025 +98 days
Sold 20,000 shares at $50.41 ($1M)
Mottola Frank, SVP, Chief Tech. Ops. Officer
10b5-1 planSold 56.3% of holdings ($1.8M position)15,496 shares left1.4x usual sizeFiling
- 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.No planMar 9, 2026 +80 days
Sold 1,623 shares at $53.65 ($87k)
Mottola Frank, SVP, Chief Tech. Ops. Officer
No 10b5-1 planSold 8.1% of holdings ($1.1M position)18,440 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 10, 2026 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Chief Tech. Ops. Officer | Form 4 sale | 1,623 | $87k | 8.1% | No plan | SEC |
| Dec 19, 2025 | Dec 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Chief Tech. Ops. Officer | Form 4 sale | 20,000 | $1M | 56.3% | Routine | SEC |
| Sep 12, 2025 | Sep 15, 2025 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Chief Tech. Ops. Officer | Form 4 sale | 5,000 | $229k | 24.4% | No plan | SEC |
| Aug 25, 2025 | Aug 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Quality, GMP, Ops, IT | Form 4 sale | 14,000 | $623k | 47.5% | Unusual | SEC |
| Nov 7, 2024 | Nov 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Quality, GMP, Ops, IT | Form 4 sale | 15,000 | $555k | 64.7% | Unusual | SEC |
| Nov 7, 2024 | Nov 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | Officer | Form 144 notice | 15,000 | $555k | Notice | SEC | |
| Nov 14, 2023 | Nov 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | SVP, Quality, GMP, Ops, IT | Form 4 sale | 1,110 | $31k | 16.3% | No plan | SEC |
| Nov 14, 2023 | Nov 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | Officer | Form 144 notice | 1,110 | $31k | Notice | SEC | |
| Mar 14, 2023 | Mar 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | Sr VP, Quality, GMP Oper. & IT | Form 4 sale | 4,780 | $172k | 50.2% | Unusual | SEC |